Approximately 75% of women with hereditary breast and ovarian cancers have germline BRCA1 mutations (gBRCA1), and 10–20% have germline BRCA2 (gBRCA2) mutations [5]. This evidence concerns the gene BRCA1 and ovarian cancer.